NCT05117164

Brief Summary

This is a multicenter randomised controlled trial to assess whether standardised enteral feeding in newborns with duct dependenty congenital heart disease decreases the risk of necrotising enterocolitis (NEC). The investigators plan to include a total 384 infants. The study will be carried out in three level III hospitals in Poland. The primary end will be NEC and/or death. Secondary end points include weight gain, hospital length of stay, time required to reach full feeding.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
384

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Aug 2022Dec 2026

First Submitted

Initial submission to the registry

October 31, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 11, 2021

Completed
9 months until next milestone

Study Start

First participant enrolled

August 10, 2022

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

July 20, 2022

Status Verified

July 1, 2022

Enrollment Period

3.4 years

First QC Date

October 31, 2021

Last Update Submit

July 16, 2022

Conditions

Keywords

congenital heart diseasenutritiongrowthnewborn

Outcome Measures

Primary Outcomes (2)

  • Proportion of final diagnosis of necrotizing enterocolitis (NEC).

    Number of infants diagnosed with NEC.

    up to two weeks life

  • Proportion of death

    Death rate.

    up to two weeks life

Secondary Outcomes (10)

  • growth

    Number of infants with a significant median change from baseline within 12 months

  • Proportion of number of interrupted feedings

    final value within 4 weeks

  • Final median value of Vasoactive support

    within 4 weeks

  • Median change from baseline of protein intake

    within 4 weeks

  • Median change from baseline of caloric intake

    within 4 weeks

  • +5 more secondary outcomes

Other Outcomes (1)

  • Proportion of final value of age at transfer

    4 weeks

Study Arms (2)

control group

NO INTERVENTION

Patients will receive enteral feeding based on the practice of the leading physician.

intervention

EXPERIMENTAL

Infants will receive enteral feeding based on the following protocol. Enteral nutrition Minimal enteral nutrition (MEN) will begin within 72 hours life at 10 to 20. mL/kg/day, via bolus gravity breast milk/donor human milk. MEN will not be included in the caloric goals. Advancements in feeding will be set at 20-30 mL/kg/day, but not more than 10ml per feeding portion to reach a goal of 150ml/kg/day, but not than 120ml/kg/day cases of fluid restriction). The goal will be to reach an overall daily caloric intake of minimum 100kcal/kg/d.

Other: enteral feeding as per predefined protocol

Interventions

Infants will receive enteral feeding based on the following protocol. Enteral nutrition Minimal enteral nutrition (MEN) will begin within 72 hours life at 10 to 20. mL/kg/day, via bolus gravity breast milk/donor human milk. MEN will not be included in the caloric goals. Advancements in feeding will be set at 20-30 mL/kg/day, but not more than 10ml per feeding portion to reach a goal of 150ml/kg/day, but not than 120ml/kg/day cases of fluid restriction). The goal will be to reach an overall daily caloric intake of minimum 100kcal/kg/d.

intervention

Eligibility Criteria

Age1 Minute - 72 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Duct dependent congenital heart disease
  • Term infants
  • Parental/legal guardian consent

You may not qualify if:

  • Potential contradictions to early central feeding
  • Feeding intolerance
  • Hemodynamic instability
  • Death
  • \> 50% formula based enteral feeding
  • Birth weight less than 2500g

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Neonatology and Neonatal Intensive Care Warsaw Medical University

Warsaw, 00-315, Poland

Location

Princess Anna Mazowiecka Hospital

Warsaw, 00-315, Poland

Location

Related Publications (1)

  • Seliga-Siwecka J, Plotko A, Wojcik-Sep A, Bokiniec R, Latka-Grot J, Zuk M, Furmanczyk K, Zielinski W, Chrzanowska M. Effect of standardized vs. local preoperative enteral feeding practice on the incidence of NEC in infants with duct dependent lesions: Protocol for a randomized control trial. Front Cardiovasc Med. 2022 Sep 8;9:893764. doi: 10.3389/fcvm.2022.893764. eCollection 2022.

MeSH Terms

Conditions

Enterocolitis, NecrotizingDeathHeart Defects, Congenital

Interventions

Enteral Nutrition

Condition Hierarchy (Ancestors)

EnterocolitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Feeding MethodsTherapeuticsNutritional SupportNutrition Therapy

Study Officials

  • Renata Bokiniec, MD PhD

    Medical University of Warsaw

    STUDY CHAIR
  • Joanna Seliga-Siwecka, MD PhD

    Medical University of Warsaw

    STUDY DIRECTOR
  • Ariel Płotko

    Medical University of Warsaw

    PRINCIPAL INVESTIGATOR
  • Agata Wojcik-Sep

    Medical University of Warsaw

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ariel Płotko, MD

CONTACT

Renata Bokiniec, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 31, 2021

First Posted

November 11, 2021

Study Start

August 10, 2022

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

July 20, 2022

Record last verified: 2022-07

Locations